Many migraine sufferers can predict their migraine attack

June 1, 2011

As many as one-third of sufferers of migraine with aura experience forewarning symptoms even the day before an attack that might create an opportunity for intervention and prevention. Later during the actual migraine episode then a significant number of migraine sufferers experience aura prior to an attack, which is characterized by visual disturbances, illusions, zigzag lines, blind spots, speech disturbances, and tingling or numbness on one side of the body.

Migraine scientists meeting this week are considering this subject, among others, at the annual scientific conference of the American Headache Society.

" is for many people a that starts hours or day similar to gathering clouds before the storm, followed by the thunderous pain of the ," Dr. Purdy said. "The premonitory phase is well-documented but only recently have scientists considered if migraine can be treated before a patient is in full attack mode."

Symptoms are often easily recognized by patients, he said, and can include mood changes - a sense of sadness or euphoria - fatigue, problems with concentration, yawning and pallor, increasing sensitivity to light and sound and a general feeling that the attack is about to begin." In some ways, it's very much like the PMS that many women report before their ."

Dr. Purdy stressed that the premonition is biologic, not psychological. "Until we fully understand the neurobiology of this phenomenon, our advice to patients is to stay alert to the presence of these symptoms and slow down to allow the body to adjust to what maybe coming if a migraine occurs."

The session "Premonitory Phase of Migraine," Chaired by Andrew Charles, MD and Joel R. Saper, MD at 8:30 am, Saturday, June 4 in the Grand Hyatt Washington. Dr. Charles is Professor and Director, Headache Research and Treatment Program, Department of Neurology at the David Geffen School of Medicine at UCLA. Dr. Saper is Founder and Director of the Michigan Headache and Neurological Institute in Ann Arbor, Michigan. Top scientists will discuss the mechanisms of the premonitory phase and recent imaging research and treatment.

Treatment during this phase of an attack, especially with triptans, has been shown to be effective with some patients. Werner J. Becker, MD, says in his work with medications administered in the premonitory phase of attack.

"We found that headache prevention is possible when a triptan is administered during the premonitory period," Dr. Becker said. "And those that did occur appeared to be milder." Triptans are a class of drugs that constrict blood vessels in the brain and relieve swelling that is associated with migraine pain.

About 500 migraine researchers and clinical specialists are expected to attend the four-day conference.

Related Stories

Recommended for you

Antibody found that fight MERS coronavirus

July 28, 2015

(Medical Xpress)—An international team of researchers has found a MERS neutralizing antibody—a discovery that could perhaps lead to a treatment for people infected with the virus. In their paper published in Proceedings ...

Experimental MERS vaccine shows promise in animal studies

July 28, 2015

A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines. ...

Can social isolation fuel epidemics?

July 21, 2015

Conventional wisdom has it that the more people stay within their own social groups and avoid others, the less likely it is small disease outbreaks turn into full-blown epidemics. But the conventional wisdom is wrong, according ...

Lack of knowledge on animal disease leaves humans at risk

July 20, 2015

Researchers from the University of Sydney have painted the most detailed picture to date of major infectious diseases shared between wildlife and livestock, and found a huge gap in knowledge about diseases which could spread ...

IBD genetically similar in Europeans and non-Europeans

July 20, 2015

The first genetic study of inflammatory bowel disease (IBD) to include individuals from diverse populations has shown that the regions of the genome underlying the disease are consistent around the world. This study, conducted ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.